Results 31 to 40 of about 4,267 (203)

suPAR and Team Nephrology [PDF]

BMC Medicine, 2014
Primary focal segmental glomerulosclerosis (FSGS) accounts for nearly 10 % of patients who require renal replacement therapy. Elevated circulating levels of soluble urokinase receptor (suPAR) have been identified as a biomarker to discriminate primary FSGS from other glomerulopathies.
openaire   +2 more sources

The Prognostic Value of suPAR Compared to Other Inflammatory Markers in Patients with Severe Sepsis [PDF]

, 2012
It has been suggested that soluble urokinase plasminogen activator (suPAR) can be used as a marker of disease severity and risk of mortality in sepsis. The aim with the present study was to compare plasma levels of suPAR in patients with severe sepsis to
Bodelsson, Mikael, Berkestedt, Ingrid,, Gustafsson, Anna,, Gustafsson, Anna, Bodelsson, Mikael,, Ljunggren, Lennart,, Ingrid Berkestedt, Berkestedt, Ingrid, Lennart Ljunggren, Mikael Bodelsson, Lund University., Anna Gustafsson, Ljunggren, Lennart   +12 more
core   +1 more source

Soluble urokinase receptor (SuPAR) in COVID-19-Related AKI

, 2020
Background AKI commonly occurs in patients with coronavirus disease 2019 (COVID-19). Its pathogenesis is poorly understood. The urokinase receptor system is a key regulator of the intersection between inflammation, immunity, and coagulation, and soluble ...
Solomonidi, N., Altintas, I., Nehlin, J.O., Kurth, F., Pop-Busui, R., Gamst-Jensen, H., Kolonia, K., Keitel, V., Sander, L.E., Chalkias, A., Feroze, R., Pantazopoulos, I., O'Hayer, P., Saridaki, M., Lindstrøm, M.B., Anderson, E., Zhao, P., International Study of Inflammation in COVID-19, Blakely, P., Meloche, C., Stauning, M.A., Berlin, H., Zhao, L., Loosen, S.H., Tsilika, M., Laou, E., Mohr, R., Reiser, J., Adami, M.-E., Rasmussen, L.J.H., Eugen-Olsen, J., Lekakis, V., Padalia, K.J., Kallemose, T., Parvaiz, I., Andersen, O., Skoulakis, A., Azam, T.U., Loosen, S., Tingleff, J., Houlind, M.B., Hayek, S.S., Jochum, C., Tacke, F., Stauning, M., Tober-Lau, P., Perry, D., Giamarellos-Bourboulis, E.J., Pan, M., Rasmussen, C., Bitar, A., Kaakati, R., Shadid, H., Pennathur, S., Arnaoutoglou, E., Luedde, T., Shadid, H.R.   +56 more
core   +3 more sources

The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia

Turkish Journal of Hematology, 2016
INTRODUCTION: The soluble urokinase plasminogen activator receptor (suPAR) is a soluble form of the urokinase plasminogen activator receptor expressed in various immune and cancer cells.
Nergiz Erkut, Ahmet Menteşe, Hasan Mücait Özbaş, Nilay Ermantaş, Ayşegül Sümer, Asım Örem, Mehmet Sönmez   +6 more
doaj   +1 more source

Index of Body Inflammation for Maxillofacial Surgery Purpose-to Make the Soluble Urokinase-Type Plasminogen Activator Receptor Serum Level Independent on Patient Age

Applied Sciences, 2021
Background: The serum suPAR level is affected in humans by it increases with age. Therefore it makes difficult interpretation and any comparison of age varied groups.
Marcin Kozakiewicz, Magdalena Trzcińska-Kubik, Rafał Nikodem Wlazeł   +2 more
doaj   +1 more source

Diagnostic and prognostic value of lipopolysaccharide binding protein and soluble urokinase plasminogen activator receptor in dogs with parvoviral enteritis [PDF]

Eurasian Journal of Veterinary Sciences, 2023
Aim: The aim of this study was to evaluate the diagnostic and prognostic values of lipopolysaccharide binding protein (LBP) and soluble urokinase plasminogen activator receptor (suPAR) in dogs with parvoviral enteritis (CPV).
Alparslan Burak Gucsav, Enes Akyuz
doaj  

Soluble urokinase plasminogen activator receptor: a novel biomarker of pediatric community-acquired and hospitalacquired pneumonia

The Turkish Journal of Pediatrics, 2022
Background. Soluble urokinase plasminogen activator receptor (suPAR) is an emerging biomarker in different clinical disorders but data in pediatric pneumonia is scarce.
Muhammad Said El-Mekkawy, Shimaa El-Shafey Soliman, Nagwan Yossery Saleh   +2 more
doaj   +1 more source

Risk Factors Associated with Serum Levels of the Inflammatory Biomarker Soluble Urokinase Plasminogen Activator Receptor in a General Population

Biomarker Insights, 2014
The soluble urokinase plasminogen activator receptor (suPAR) is a biomarker of mortality risk in various patient populations. However, little is known about the implications of lifestyle for suPAR levels in the general population. Lifestyle, demographic,
Thomas H. Haupt, Thomas Kallemose, Steen Ladelund, Line J. H. Rasmussen, Christian W. Thorball, Ove Andersen, Charlotta Pisinger, Jesper Eugen-Olsen   +7 more
doaj   +1 more source

SuPAR-based choice of the management strategy in kidney transplant recipients with infection

Alʹmanah Kliničeskoj Mediciny, 2020
Background: Infectious complications are a major problem in transplantology of today. Soluble urokinase-type plasminogen activator receptor (suPAR) could be one of the markers of infection in kidney transplant recipients.
N. V. Rapetskaya, K. S. Komissarov, O. V. Kalachik   +2 more
doaj   +1 more source

Detection of Inflammatory Biomarker suPAR in COVID-19 Disease With CHORUS TRIO Instrument

Biomarker Insights, 2023
Background: Deregulation in the urokinase-type plasminogen activator receptor (uPA/uPAR) system is reported in many diseases where the immune system is activated.
Cerutti Helena, Tesi Giulia, Cartocci Alessandra, Guerranti Roberto, Silvestrini Caterina, Gori Sabrina, Bianciardi Simone, Bandini Tommaso, Brogi Alessandra, Leoncini Roberto   +9 more
doaj   +1 more source